BU-NOT-SET

CONTACT US
Optimising formulation to improve solubility ready for Phase III
  • Drug product
Optimising formulation
Case study
Trends emerging in capsule dosage form development
  • Drug product
  • Industry trends
Capsules
Insight
Licensing portfolio
  • Corporate
containers
Fact sheet
Key trends in pharmaceutical outsourcing
  • Industry trends
Hands
Insight
The latest trends and innovations in oral drug delivery
  • Drug product
  • Industry trends
Pharma Roundtable
Insight
Recipharm invests in African vaccine production
  • Corporate
Building
Insight
The future of oral solid dose development and manufacturing
  • Drug product
  • Industry trends
Products
Insight
Sustainability Report 2021
  • Sustainability
Sustainability report
Report
Treating long-COVID with Erdosteine
  • Corporate
Treating long-COVID with Erdosteine
Insight
Insight
  • Manufacturing
Is outsourcing the most viable pathway for innovators?
Case study
  • Drug product
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
Insight
  • Industry trends
Recipharm Wins two 2020 CMO Leadership Awards
Insight
  • Corporate
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API product list
Insight
  • Drug substance
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
Insight
  • Industry trends
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19